Personality-targeted web-based prevention of common mental disorders in adolescents
Personality-targeted web-based prevention of common mental disorders in adolescents
批准号:
MR/N014391/1
负责人:
Peter Musiat
金额:
$17.47万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --
中文摘要
在英国,十分之一的青少年患有可诊断的精神障碍,类似比例的青少年表现出低于临床阈值的症状。这个年龄组最普遍的问题是抑郁、焦虑、药物滥用和饮食失调,这些问题在青春期首次或高峰发作。这些精神障碍可对青少年的发育造成干扰,并产生深远的影响,其对个人和社会经济的全面影响往往要到生命的后期才显现出来,这些常见的精神障碍在症状、根本原因和促成因素方面有相当大的重叠。例如,这些常见的精神障碍与共同的个性因素有关,例如焦虑的个性、高度完美主义、冲动和/或低自尊。有几项以学校为基础的干预措施旨在预防精神障碍的发生。然而,我们最近对这一年龄组的这些干预措施的分析和审查发现,其中大多数只针对单一疾病,并且只针对已经表现出精神疾病症状的个人。这种传统的方法没有解决风险因素或精神病理学的重叠,因此在时间、精力和成本方面效率低下。此外,只针对出现症状的儿童和青少年可能会被视为污名化和病态化。在这项早期研究中,我们的目标是开发和评估以学校为基础的干预措施的可行性,针对常见精神障碍的共同人格风险因素。该干预措施将基于现有的干预措施,我们已经为本科大学生开发了该干预措施,该干预措施已在一项大型研究中证明了有效性。干预措施将在课堂上以及通过互联网进行。这种混合方法将允许向班级或年级组中的所有儿童提供干预,而不会使个人蒙受耻辱,并且还允许为每个用户提供一定程度的个性化干预内容,以便最佳地支持他们的心理健康需求。
英文摘要
One in ten adolescents in the UK suffers from a diagnosable mental disorder and a similar proportion shows symptoms below clinical threshold. The most prevalent problems in this age group are depression, anxiety, substance misuse and disordered eating, which have their first or peak onset during adolescence. These mental disorders can cause disruption to the development of adolescent and have far-reaching effects, whose full personal and socio-economic impact often only becomes apparent at a later stage in life.There is considerable overlap between these common mental disorders with regard to symptoms, underlying causes and contributing factors. For example, these common mental disorders are associated with shared personality factor, such as an anxious personality, high perfectionism, impulsivity and/or low self-esteem. Several school-based interventions aiming to prevent the onset of mental disorders exist. However, our recent analysis and review of these interventions for this age group found that most of them address only single disorders and are only designed for individuals already expressing symptoms of mental ill-health. This traditional approach does not address the overlap in risk factors or psychopathology and thus is inefficient with regard to time, effort and cost. In addition, targeting only children and adolescents who show symptoms can be experienced as stigmatising and pathologising.In this early phase study, we are aiming to develop and evaluate the feasibility of a school-based intervention targeting shared personality risk factors of common mental disorders. The intervention will be based on an existing intervention, which we have developed for undergraduate university students, which has demonstrated efficacy in a large study. the intervention will be delivered in the classroom as well as through the internet. This mixed approach will allow for the intervention to be delivered to all children in a class or year group without stigmatising individuals and also allow for a degree of personalising the content of the intervention for each user in order to optimally support them with their mental health needs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
抑制FGF19/FGFR4信号通路促进肺鳞癌细胞焦亡及免疫增效的机制研究
-
批准号:32100565
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李凡
-
依托单位:
黑色素瘤中PPM1D介导的去磷酸化修饰调控NRAS蛋白功能的机制研究
-
批准号:32100579
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:尹成骞
-
依托单位:
Tousled like kinase介导青光眼中视网膜神经节细胞死亡的作用和机制
-
批准号:32000518
-
项目类别:青年科学基金项目
-
资助金额:16.0万元
-
批准年份:2020
-
负责人:赵春月
-
依托单位:
SAMMSON-CARF-p53信号轴调控黑色素瘤适应性耐药的机制研究
-
批准号:32000541
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:韩戍君
-
依托单位:
CDKL3在肾细胞癌中功能与分子机制的研究及小分子抑制剂的合成与表征
-
批准号:31970721
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:盛韧
-
依托单位:
铁氧还蛋白还原酶FDXR促进雌激素受体阳性乳腺癌内分泌治疗耐药的分子机制研究
-
批准号:31970737
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张静
-
依托单位:
SIRT1调控突变型p53肿瘤细胞死亡的分子机制研究
-
批准号:31970689
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:闵军霞
-
依托单位: